TWiV reviews the new nomenclature for SARS-CoV-2 variants, effectiveness of Pfizer/BioNTech vaccine against variants, modified Moderna vaccine against variants, impact of COVID-19 interventions on influenza in China and the U.S., and binding of RaTG13 spike protein to ACE2 of multiple species.
Links for This Episode
- of SARS-CoV-2 variants (WHO) 3:35.
- Pfizer-BioNTech vaccine effective against (Lancet) 17:34.
- Novavax vaccine effective against (NEJM) 23:28.
- Moderna updated vaccine against (medRxiv) 31:11.
- Impact of against influenza (Nat Comm) 44:10.
- to various ACE2 proteins (Cell) 1:03:14.
- Timestamps by . Thanks!
Weekly Science Picks 1:33:28
Dickson –.
Brianne –.
Rich – .
Alan – reported in MMWR 40 years ago; on disease.
Vincent –
Send your virology questions and comments to twiv@microbe.tv
Subscribe (free): , , , .
Become a of TWiV!
Intro music is by .